Portola Pharmaceuticals
Our Innovation Pushing the Boundaries of Science Our research and development is fueled by a relentless sense of urgency and an steadfast commitment to helping more rare disease patients and their families around the world.Learn how we are addressing some of today’s most pressing rare disease challenges by investigating in new targets, modalities and technologies, with more opportunities for innovation than ever before. To create meaningful advances in rare disease research, it takes an innovati
Basic Information
- Category: Cardiovascular
- Founded: 2003
- Headquarters: South San Francisco, CA
- Website: portola.com
Evidence and Sources
- Portola Pharmaceuticals — Official Website (official)
Citation Guidance
Explore Cardiovascular profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Portola Pharmaceuticals.
- Canonical profile: https://brandsource.ai/brands/portola-pharmaceuticals
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/portola-pharmaceuticals/json-ld
- Citation profile API: https://brandsource.ai/api/brands/portola-pharmaceuticals/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (74/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2025-10-28T04:26:09.309Z
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Our Innovation Pushing the Boundaries of Science Our research and development is fueled by a relentless sense of urgency and an steadfast commitment to helping more rare disease patients and their families around the world.Learn how we are addressing some of today’s most pressing rare disease challenges by investigating in new targets, modalities and technologies, with more opportunities for innovation than ever before. To create meaningful advances in rare disease research, it takes an innovati
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.